Cubresa is pleased to be featured in Dotmed’s Health Care Business News Magazine – June 2020 edition.
The article, found on page 56, focuses on innovation in the PET and SPECT markets. Dr. James Schellenberg, Cubresa’s Founder and CEO is pleased to share information highlighting the value of its NuPET preclinical insert for SARS-CoV-2 research in BSL 3 environments, as well as applications for the clinical BrainPET insert currently under development. To read more, please click on the following link.
